Results
20,303 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 40 | Simon JoshDirector, Chief Executive Officer |  FNKOFunko, Inc.Open-market sale | SELL | $786K 136.3K sh | Sep 4, 2026 traded Sep 3, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 40 | Simon JoshDirector, Chief Executive Officer | FNKOFunko, Inc. Open-market sale | SELL | $786K 136.3K sh | Sep 4, 2026 traded Sep 3, 2026 | |
Tang StanleyDirector |
 DASHDoorDash, Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $1.87M 8,277 sh |
| Sep 4, 2026 traded Sep 2, 2026 |
| 40 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Open-market sale | SELL | $133K 5,130 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 40 | Courtney PhillipsGC and Corp. Secretary | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $46K 1,738 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 40 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $118K 4,481 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 39 | Turner Matthew BakerPRES., PATIENT AFFORDABILITY |  PAYSPaysign, Inc.Open-market sale | SELL | $63K 15.1K sh | Sep 4, 2026 traded Feb 3, 2026 |
| 39 | Cunningham Bradley KramerChief Technology Officer | PAYSPaysign, Inc. Open-market sale | SELL | $73K 10.0K sh | Sep 4, 2026 traded May 29, 2026 |
| 38 | Pollitzer AdamDirector, Chief Executive Officer |  NMIHNMI Holdings, Inc.Open-market sale | SELL | $7.75M 172.7K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 38 | Shauli AviChief Technology Officer |  RSKDRISKIFIED LTD.Open-market sale | SELL | $193K 30.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 38 | Notman TaliCHIEF REVENUE OFFICER |  FROGJFrog LtdOpen-market sale | SELL | $1.73M 19.2K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 36 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $83K 3,207 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 36 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $37K 1,375 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 36 | Spice Adam C.Chief Financial Officer |  RKLBRocket Lab CorpOpen-market sale · 10b5-1 plan | SELL | $4.59M 72.9K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 36 | Marquina JavierDirector |  LPALogistic Properties of the AmericasOpen-market sale | SELL | $5,562 1,800 sh | Sep 4, 2026 traded Sep 1, 2026 |
| 36 | Spice Adam C.Chief Financial Officer | RKLBRocket Lab Corp Open-market sale · 10b5-1 plan | SELL | $4.19M 67.3K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 36 |  Gilbert Ray Cisneros, Jr.DSelf |  IBMINTERNATIONAL BUSINESS MACHINES CORPSale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 36 | Simon JoshDirector, Chief Executive Officer | FNKOFunko, Inc. Open-market sale | SELL | $267K 45.5K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 36 | Courtney PhillipsGC and Corp. Secretary | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $6,590 243 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 36 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $74K 2,800 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 35 | Gilbert Ray Cisneros, Jr.DSelf |  SPXCSPX Technologies, Inc.Partial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 16, 2026 |
| 35 | Gilbert Ray Cisneros, Jr.DSelf |  LAMRLAMAR ADVERTISING CO/NEWPartial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 16, 2026 |
| 35 | Spetzler David BaxleyPresident |  CAICaris Life Sciences, Inc.Open-market sale | SELL | $2.95M 119.2K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 35 | Gilbert Ray Cisneros, Jr.DSelf |  CRNXCrinetics Pharmaceuticals, Inc. - Common StockSale | SELL | $15K – $50K | Sep 4, 2026 traded Jul 30, 2026 |
| 35 | Lantheus Alpha Therapy, LLC10% Owner |  CATXPerspective Therapeutics, Inc.Open-market sale | SELL | $246K 78.1K sh | Sep 4, 2026 traded Aug 31, 2026 |
| 34 | Lacerte Rene A.Director, CEO |  BILLBILL Holdings, Inc.Open-market sale | SELL | $547K 11.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 34 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $513K 10.2K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 34 | Viozzi Vincent AnthonySr. VP & Chief Inv Officer |  DGICADONEGAL GROUP INCOpen-market sale | SELL | $44K 2,282 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 34 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $769K 15.4K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 33 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $509K 2,265 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 33 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $516K 2,271 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 33 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $559K 2,500 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 32 | Cunningham Bradley KramerChief Technology Officer | PAYSPaysign, Inc. Open-market sale | SELL | $23K 3,000 sh | Sep 4, 2026 traded Jun 1, 2026 |
| 32 | Courtney PhillipsGC and Corp. Secretary | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $567 22 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 32 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $3,325 129 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 32 | Bonanni Mark EmilioEVP, CRO, Commercial |  OUTOUTFRONT Media Inc.Open-market sale | SELL | $101K 3,385 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  CRDOCredo Technology Group Holding LtdSale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 2, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  FDXFEDEX CORPSale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 21, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  CMCSACOMCAST CORPSale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |
| 31 | Lantheus Alpha Therapy, LLC10% Owner | CATXPerspective Therapeutics, Inc. Open-market sale | SELL | $112K 35.8K sh | Sep 4, 2026 traded Sep 1, 2026 |
| 31 | Gilbert Ray Cisneros, Jr.DSelf |  ZTSZoetis Inc.Partial sale | SELL | $1,001 – $15K | Sep 4, 2026 traded Jul 17, 2026 |